Search
Extraordinary $15-million gift will create unique powerhouse initiative to fight infections
April 26th, 2018 Releases A $15-million gift from the visionary Montreal-based Doggone Foundation will launch the McGill Interdisciplinary Initiative in Infection and Immunity, a unique and highly collaborative endeavour that will harness the scientific …
Viral communications hacking boosts Leishmania infections
February 7th, 2019 Releases From L to R : Martin Olivier (Principal Investigator) with Alonso da Silva Lira Filho (PhD student) and Caroline Martel (Research assistant) in their laboratory at the Research Institute of the McGill University Health Centre. …
Anti-TB drugs can increase risk of TB re-infection
March 22nd, 2019 Releases Montreal – Current treatments for tuberculosis (TB) are very effective in controlling TB infection caused by Mycobacterium tuberculosis (Mtb). They don’t, however, always prevent reinfection. Why this happens is one of the …
RI-MUHC researcher Nitika Pant Pai advocates improved access to HIV self-testing for Canadians
December 1st, 2020 News Research Canada approves HIV self-testing kit ahead of World AIDS Day 2020 Source: CMAJ and RI-MUHC. People with HIV can live long and healthy lives. A test, diagnosis, and connection to appropriate care and services are …
Inspiring day for those working towards a TB-free world
June 13th, 2018 The words of Canada’s youngest Inuit leader Natan Obed made an instant impact on the 100 scientists, students and healthcare professionals gathered at the Research Institute of the McGill University Health Centre on June 1 as part of the …
Beyond Killing Tuberculosis
May 11th, 2018 Releases Historically, our view of host defense against infection was that we must eliminate pathogens to eradicate disease. However, this perspective has recently been challenged as scientists have taken a lesson from plant biologists …
Latent TB Treatment: Shorter is Better
August 1st, 2018 Releases Research Montreal – Treatment of latent tuberculosis is set to transform after a pair of studies from the Research-Institute of the McGill University Health Centre (RI-MUHC) revealed that a shorter treatment was safer and more …
Complete make-over in fight of multidrug-resistant tuberculosis
September 6th, 2018 Releases Research Montreal – Several new medicines have been found to be more effective than traditional ones used to treat multidrug-resistant tuberculosis (MDR-TB), according to a new international collaborative study led by Dr. Dick …
Life-saving epinephrine underused during anaphylaxis outside of hospital, study finds
September 7th, 2018 Releases MONTREAL - Fewer than half of adults and children experiencing food-induced anaphylaxis use their epinephrine autoinjector (EAI) before being treated at a hospital emergency room, according to a new Canadian study. “It’s a …
New means to fight 'un-killable' bacteria in healthcare settings
September 13th, 2018 Releases Research Montreal – Scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) have identified new means of fighting drug-tolerant bacteria, a growing global threat as menacing as drug-resistant …